OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of new antimicrobials for Gram-negative infections in daily clinical practice
Matteo Bassetti, Antonio Vena, Denise Battaglini, et al.
Current Opinion in Infectious Diseases (2020) Vol. 33, Iss. 6, pp. 495-500
Closed Access | Times Cited: 13

Showing 13 citing articles:

Early appropriate diagnostics and treatment of MDR Gram-negative infections
Matteo Bassetti, Souha S. Kanj, Pattarachai Kiratisin, et al.
JAC-Antimicrobial Resistance (2022) Vol. 4, Iss. 5
Open Access | Times Cited: 30

PmrAB, the two-component system of Acinetobacter baumannii , controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions
Noriteru Yamada, Go Kamoshida, Tsukasa Shiraishi, et al.
Journal of Bacteriology (2024) Vol. 206, Iss. 5
Closed Access | Times Cited: 6

Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal
Pablo Vidal, Sandra Campos-Fernández, Elena Cuenca-Fito, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 178-178
Open Access

The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation
Josep Ferrer, María Ángeles Clari, Estela Giménez, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 105, Iss. 2, pp. 115847-115847
Open Access | Times Cited: 18

Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections
Matteo Bassetti, Daniele Roberto Giacobbe, Nadia Castaldo, et al.
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 6, pp. 748-755
Closed Access | Times Cited: 11

National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa
Aurélien Dinh, Alexandre Bleibtreu, Clara Duran, et al.
Antibiotics (2024) Vol. 13, Iss. 12, pp. 1152-1152
Open Access | Times Cited: 1

β-Lactam antibiotics
Jed F. Fisher, Yuanyuan Qian, Shahriar Mobashery
Elsevier eBooks (2023), pp. 67-113
Closed Access | Times Cited: 3

Bacteremia with Carbapenemase-Producing Enterobacterales in Immunocompromised Patients Colonized with These Bacteria
Diana Averbuch, Liya Moshkovitz, Shlomi Ilan, et al.
Microbial Drug Resistance (2022) Vol. 28, Iss. 5, pp. 593-600
Closed Access | Times Cited: 5

Macrolide, lincosamide, glycopeptide, and other antibacterial antibiotics
Yuanyuan Qian, Shahriar Mobashery, Jed F. Fisher
Elsevier eBooks (2023), pp. 157-213
Closed Access | Times Cited: 2

Combating antimicrobial resistance with cefiderocol for complicated infections involving the urinary tract
Hongmei Wang, Brittany N. Palasik
Therapeutic Advances in Urology (2022) Vol. 14
Open Access | Times Cited: 4

Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
Sarah L. Anderson, Matteo Bassetti, Arduino A. Mangoni
Drugs in Context (2021) Vol. 10, pp. 1-5
Open Access | Times Cited: 3

New antibiotics for the treatment of nonfermenting Gram-negative bacteria
Matteo Bassetti, Chiara Russo, Antonio Vena, et al.
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 6, pp. 701-709
Open Access

Page 1

Scroll to top